Grants & Programs

CVC Trials Network

Established in 2001 through a partnership between the Cancer Research Institute and Ludwig Cancer Research, the CVC Trials Network is a coordinated global research team composed of more than 60 of the world's top clinical immunologists.

The Network meets in person twice yearly, collaborates year-round on clinical trials, and regularly shares new findings, questions, and ideas for trials.

The CVC Trials Network is distinguished by a centrally coordinated approach and field-leading expertise in immunological monitoring and immunotherapy trial design.
 

Global Membership

United States

  • James P. Allison, Ph.D., The University of Texas MD Anderson Cancer Center
  • Shahab Asgharzadeh Asgharzadeh, M.D., University of Southern California
  • Djordje Atanackovic, M.D., University of Utah
  • Mark Awad, M.D., Ph.D., Dana-Farber Cancer Institute
  • Nina Bhardwaj, M.D., Ph.D., Icahn School of Medicine at Mount Sinai
  • Margaret Callahan, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Timothy A. Chan, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Aude G. Chapuis, M.D., Fred Hutchinson Cancer Research Center
  • Hearn Jay Cho, M.D., Ph.D., Icahn School of Medicine at Mount Sinai
  • Adam D. Cohen, M.D., Memorial Sloan Kettering Cancer Center
  • Patrick Dillon, M.D., University of Virginia Health System
  • Gavin P. Dunn, M.D., Ph.D., Washington University in Saint Louis
  • Lawrence Fong, M.D., University of California, San Francisco
  • Leena Gandhi, M.D., Ph.D., Dana-Farber Cancer Institute
  • Sacha Gnjatic, Ph.D., Icahn School of Medicine at Mount Sinai
  • Philip D. Greenberg, M.D., Fred Hutchinson Cancer Research Center, University of Washington
  • F. Stephen Hodi Jr., M.D., Dana-Farber Cancer Institute, Harvard Medical School
  • Siwen Hu-Lieskovan, Ph.D., University of California, Los Angeles
  • Elizabeth M. Jaffee, M.D., The Johns Hopkins University School of Medicine
  • Carl H. June, M.D., Perelman School of Medicine, University of Pennsylvania
  • Achim Jungbluth, M.D., Memorial Sloan Kettering Cancer Center
  • Thomas J. Kaley, M.D., Memorial Sloan Kettering Cancer Center
  • Lana E. Kandalaft, Pharm.D., Ph.D., University of Pennsylvania and Lausanne University Hospital (CHUV), Switzerland
  • John M. Kirkwood, M.D., University of Pittsburgh Medical Center
  • Matthew F. Krummel, Ph.D., University of California, San FranciscoAlexander M. Lesokhin, M.D., Memorial Sloan Kettering Cancer Center
  • Kunle Odunsi, M.D., Ph.D., Roswell Park Cancer Institute
  • Hideho Okada, M.D., Ph.D., University of California, San Francisco
  • Drew M. Pardoll, M.D., Ph.D., The Johns Hopkins University School of Medicine
  • Marshall R. Posner, M.D., Icahn School of Medicine at Mount Sinai
  • Osama E. Rahma, M.D., University of Virginia Health System
  • David A. Reardon, M.D., Dana-Farber Cancer Institute
  • Antoni Ribas, M.D., Ph.D., UCLA Medical Center
  • Michel Sadelain, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Yvonne Saenger, M.D., Columbia University Medical Center
  • Jonathan D. Schoenfeld, M.D., Dana-Farber Cancer Institute
  • Neil H. Segal, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Padmanee Sharma, M.D., Ph.D., The University of Texas MD Anderson Cancer Center
  • Andrew G. Sikora, M.D., Baylor College of Medicine
  • Craig L. Slingluff Jr., M.D., University of Virginia Health System
  • Alexandra Snyder Charen, M.D., Memorial Sloan Kettering Cancer Center
  • Pramod K. Srivastava, Ph.D., M.D., University of Connecticut School of Medicine
  • Mario Sznol, M.D., Yale Cancer Center
  • Suzanne L. Topalian, M.D., The Johns Hopkins University School of Medicine
  • Cornelia L. Trimble, M.D., The Johns Hopkins University School of Medicine
  • Takemasa Tsuji, Ph.D., Roswell Park Cancer Institute
  • Marcel R.M. van den Brink, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Robert H. Vonderheide, M.D., D.Phil., University of Pennsylvania
  • Ralph R. Weichselbaum, M.D., University of Chicago
  • E. John Wherry, Ph.D., University of Pennsylvania
  • Jedd D. Wolchok, M.D., Ph.D., Memorial Sloan Kettering Cancer Center, Ludwig Cancer Research
  • Cassian Yee, M.D., The University of Texas MD Anderson Cancer Center
  • Dmitriy Zamarin, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Hassane M. Zarour, M.D., University of Pittsburgh Medical Center
  • Lei Zheng, M.D., Ph.D., Johns Hopkins University School of Medicine

Europe

  • Maha Ayyoub, Ph.D., Institut Gustav-Roussy, Villejuif, France
  • Luigi Buonaguro, M.D., National Cancer Institute Pascale, Italy
  • Vincenzo Cerundolo, M.D., Ph.D., University of Oxford, United Kingdom
  • George Coukos, M.D., Ph.D., University Hospital of Lausanne, Switzerland
  • Jessica Cecile Hassel, M.D., University Clinic of Heidelberg, Germany
  • Dirk Jäger, M.D., University Clinic of Heidelberg, Germany
  • Elke Jäger, M.D., Krankenhaus Nordwest, Germany
  • Judith Kroep, M.D., Ph.D., Leiden University Medical Center, The Netherlands
  • Simon A. Laban, M.D., University of Ulm, Germany
  • James Larkin Ph.D., FRCP, The Royal Marsden NHS Foundation Trust, United Kingdom
  • Xin Lu, Ph.D., Ludwig Institute for Cancer Research, University of Oxford, United Kingdom
  • Cornelis J.M. Melief, M.D., Ph.D., Leiden University Medical Center, The Netherlands
  • Mark R. Middleton, M.D., Ph.D., University of Oxford, United Kingdom
  • Dario Neri, Ph.D., Swiss Federal Institute of Technology Zurich, Switzerland
  • Christian Ottensmeier, M.D., Ph.D., FRCP, University of Southampton, United Kingdom
  • Pedro J. Romero, M.D., University Hospital of Lausanne, Switzerland
  • Daniel E. Speiser, M.D., University Hospital of Lausanne, Switzerland
  • Danila Valmori, Ph.D., Centre de Lutte Contre Le Cancer Nantes-Atlantique, France
  • Nicolas Van Baren, M.D., Ph.D., Ludwig Cancer Research, Belgium
  • Maries van den Broek, Ph.D., University of Zürich, Switzerland
  • Benoit J. Van den Eynde, M.D., Ph.D., Ludwig Institute for Cancer Research, Belgium
  • Pierre van der Bruggen, Ph.D., Ludwig Institute for Cancer Research, Belgium
  • Magnus von Knebel Doeberitz, M.D., University Clinic of Heidelberg, Germany
  • Sjoerd Henricus van der Burg, Ph.D., Leiden University Medical Center, The Netherlands
  • Alfred Zippelius, M.D., University of Basel, Switzerland

Asia

  • Shinichi Kageyama, M.D., Mie University School of Medicine, Japan
  • Alexander Knuth, M.D., National Center for Cancer Care and Research, Hamad Medical Corporation, Qatar
  • Eiichi Nakayama, M.D., Ph.D., Kawasaki University of Medical Welfare, Japan
  • Hiroyoshi Nishikawa, M.D., Ph.D., National Cancer Center Hospital, Japan
  • Hiroshi Shiku, M.D., Mie University School of Medicine, Japan
  • Hisashi Wada, M.D., Ph.D., Osaka University, Japan

Australia

  • Jonathan S. Cebon, Ph.D., FRACP, Austin Health, Ludwig Cancer Research
  • Mark J. Smyth, Ph.D., QIMR Berghofer Medical Research Institute